U.S. Tobacco Stock News

Mosaic (MOS) just moved deeper into rare earths with a Joint Development Agreement supporting a new Pre-Feasibility Study at the Uberaba phosphogypsum project in Brazil alongside Rainbow Rare Earths. Over the past year Mosaic has been a rough ride for long term holders, with a 1 year total shareholder return down 25.3% even as the 90 day share price return has climbed 11.3%. This hints at improving momentum from a low base around the rare earths news and other recent fertilizer cycle...

Nasdaq announced an expanded partnership with Payward, parent of Kraken, to advance the Nasdaq Equity Token framework and provide market surveillance technology across Payward's trading venues. The focus on issuer protections, regulatory compliance and tokenized equity infrastructure signals Nasdaq's push to embed its technology deeper into digital asset markets and future capital flows. The investment narrative for Nasdaq will now be tested against this expanded Payward collaboration around...

Corteva, alongside Chemours and DuPont, has agreed to a long term PFAS settlement with North Carolina and 11 local entities. The agreement covers emissions claims and commits to an aggregate US$455 million payment stream over 15 years under their existing cost sharing framework. The settlement clarifies Corteva's share of PFAS related cash outflows and simplifies future escrow funding under the Chemours DuPont Corteva MOU. This may influence how investors think about long run legal overhang...

CBL & Associates Properties (CBL) edged 0.9% higher at the last close to US$54.34, leaving investors weighing that move against a near 2% decline over the past month. That recent softness sits against a much stronger backdrop for CBL & Associates Properties, with a 90 day share price return of 9.6% and a year to date share price gain of 47.1%. The 1 year total shareholder return of 89% points to momentum that has been building rather than fading. Scan how CBL & Associates Properties fits...

Kroger (KR) has affirmed a quarterly dividend of $0.39 per share, payable on December 1, 2026. This payout decision provides investors with updated income context for a stock trading near US$60. Kroger’s latest dividend call comes after an earnings update in mid August that showed higher sales and earnings per share, continued share buybacks, and new merchandising moves such as expanding its pumpkin themed Private Selection range and placing greater emphasis on private label and supplier...

DoorDash (NasdaqGS:DASH) announced a multiyear deal to become the Official On-Demand Delivery and Pick Up Partner of the NHL in Canada and the U.S. The agreement gives DoorDash exclusive on-demand delivery rights and branding across league broadcasts and digital platforms, including exposure during marquee NHL events. Marketing integrations are set to feature during high-profile moments such as the Stanley Cup Playoffs, tying in app promotions with live game coverage. This new NHL-wide...

In September 2026, Clearway Energy reshaped its finance leadership by moving CFO Sarah Rubenstein to lead a new digital and data Transformation Office at Clearway Energy Group and appointing Steven Ryder as CFO of Clearway Energy while he retains his Clearway Group CFO position. The dual-hat CFO structure and dedicated transformation role indicate management attention on tighter capital coordination and more data-driven execution across Clearway Energy’s contracted renewables portfolio. We...

Enterprise Products Partners has delivered strong multi year returns, which puts a spotlight on whether the current US$38.89 unit price lines up with the earnings behind it. With the recent move in the units, investors are asking how much of the partnership's profit power is already reflected in today’s valuation. Over the past 5 years, Enterprise Products Partners has returned 158.4%, which raises the question of whether its earnings can support the current unit price. The partnership...

Bank of America has delivered a 124.4% gain over the past 3 years, which naturally pushes investors to ask whether that share price now lines up with the returns the bank earns on its capital. Recent headlines around interest rates, unrealized bond losses and fee income only sharpen the focus on what the current valuation assumes about how efficiently this financial giant can keep using its balance sheet. Over 3 years the stock has climbed 124.4%, so the question is how much of that...

Coinbase Global moved higher recently as crypto related stocks responded to new SEC tokenization rules, a sharp Bitcoin recovery, and fresh attention on the company’s derivatives efforts after its CFTC filing for perpetual futures on major U.S. equities. The combination of SEC tokenization guidance and Coinbase Global’s push into perpetual futures highlights how regulatory clarity and product expansion could reshape its revenue mix away from purely spot crypto trading. Now the focus shifts...

On Holding has seen a sharp reset in its share price this year, and the size of that pullback puts a fresh spotlight on whether the current valuation can still be explained by its earnings power. With the stock now trading around US$27.26, the key issue is how that price lines up against what the business is actually generating in profit. The share price is down about 41.9% year to date, which puts pressure on the idea that the current market value reflects what the underlying earnings can...

FedEx (FDX) just rolled out FedEx Authenticated Delivery, a QR code based service aimed at tighter control over high value and sensitive parcels in the U.S. and Canada, giving investors a fresh product move to assess. FedEx shares have softened recently, with the 30 day share price return down 6.6% and the 90 day return down 7.6%, yet the 1 year total shareholder return of 65.5% and 5 year total shareholder return of 83.9% point to strong longer term momentum as the company rolls out new...

Pagaya Technologies (NasdaqCM:PGY) appointed Marqeta founder Jason Gardner to its Board of Directors. Gardner brings more than 20 years of fintech and payments experience, including leading Marqeta through its IPO. His board role aligns with Pagaya's focus on AI-driven lending marketplace products and payment technology. The Jason Gardner board appointment is important, but investors should weigh it alongside other Pagaya developments. Our analysis turns up 2 warning signs for Pagaya...

Digital Realty Trust (DLR) has been drawing fresh attention after a run of AI focused moves, including a new AXG partnership, the rollout of ServiceFabric MCP, a joint venture in Türkiye, and an expanded Nairobi campus. Recent trading tells a mixed story for Digital Realty Trust. The share price has eased over the past week and quarter, with the 7 day share price return down 3.43% and the 90 day share price return down 6.86%. However, the year to date share price return of 17.47% and 3 year...

MGE Energy has seen a mixed share price record in recent years, with the stock pulling back over the past 12 months after earlier gains. That leaves investors weighing whether the current price around US$74 is adequately supported by the utility's future stream of dividend payments. Over the past 5 years, MGE Energy has delivered a total return of 9.9%, which puts real weight on the question of how much of that experience can reasonably be tied to its dividend profile. The group runs a...

Linde (LIN) grabbed investor attention after its latest share price move, with the industrial gas specialist now trading around $460.40 per share on the Nasdaq. Short term performance has been mixed. Recent trading has been choppy for Linde, with the 30 day share price return down 5.57% and the 90 day share price return lower by 10.90%, even though the year to date share price return is still up 7.29%. That pullback contrasts with a 1 year total shareholder return that is slightly negative at...

Recent market research points to significant projected expansion in global RNA interference therapeutics, with Alnylam Pharmaceuticals identified as a leading participant in RNA-based treatments for hard-to-treat conditions, including hereditary transthyretin-mediated amyloidosis. The emphasis on rare disease prevalence and precision medicine investment highlights how Alnylam Pharmaceuticals's focus on hATTR and RNAi platforms ties directly into an expanding treatment universe and potential...

The latest move in FuelCell Energy (FCEL) has been sparked by legislation, not earnings. The U.S. House passed the Ratepayer Protection Act, which shifts grid upgrade costs for heavy power users such as large data centers. For context, FuelCell Energy’s recent move comes after a sharp year-to-date share price return of 121.66% and a 1-year total shareholder return of 116.63%. However, momentum has faded in recent months, with a 30-day share price return down 7.32% and a 90-day share price...

BNY (NYSE:BNY) has lost its role as depositary bank for Kazia Therapeutics' American Depositary Receipt program. Kazia Therapeutics has appointed JPMorgan Chase as the new depositary for its ADR program, replacing Bank of New York Mellon Corporation. The ADR depositary switch highlights competitive pressure on BNY's global custody and asset servicing franchise. The move by Kazia Therapeutics to shift its ADR depositary from BNY to JPMorgan Chase tells only part of the story. Take a look at 1...

Novo Nordisk (NYSE:NVO) received a positive opinion from the European Medicines Agency's CHMP for Sogroya as a treatment for idiopathic short stature in children. If approved by the European Commission, Sogroya could become the first authorised therapy for idiopathic short stature in the EU pediatric population. The opinion supports Novo Nordisk's effort to expand its rare disease and pediatric endocrinology portfolio beyond existing growth hormone deficiency indications. The CHMP backing...

Pulse Biosciences (NasdaqCM: PLSE) reported completion of 100 patient enrollment in its PRECISE-BTN thyroid nodule study using the nPulse Vybrance Percutaneous Electrode System. The PRECISE-BTN trial expanded from an original 50 patients to 100 patients across multiple participating centers. Management plans future disclosure of clinical data from PRECISE-BTN, which is intended to support potential regulatory clearance for nPulse Vybrance. The completed PRECISE-BTN enrollment matters, but it...

TTM Technologies has delivered very large gains over the past five years, which puts a sharp focus on whether the current US$117.97 share price lines up with the cash flows that support the business. With an intrinsic value estimate based on a Discounted Cash Flow (DCF) model available, the key issue is how that cash flow view compares with a stock that has already rewarded early holders in a big way. Over 5 years, the stock is up about 8x. Anyone looking at TTM Technologies today has to ask...

DHT Holdings announced a three year time charter for the 2016 built VLCC DHT Panther at a rate of $100,000 per day with a global energy company, with the contract starting in October 2026. The fixed multi year charter on a modern VLCC locks in contracted revenue for DHT Holdings and provides greater visibility on fleet utilization compared with relying purely on spot exposure. We will look at how DHT Holdings' investment narrative around cash flow stability is affected by the $100,000 daily...

T. Rowe Price Group recently launched three fully transparent actively managed equity ETFs on the NASDAQ, targeting biotech, U.S. small caps, and U.S. mid caps, with expense ratios between 0.47% and 0.59%. The new ETFs broaden T. Rowe Price Group’s active ETF shelf across key equity segments, which may support more diversified fee streams and help address competitive pressure from lower cost passive products. We will look at how T. Rowe Price Group’s investment narrative intersects with this...